Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study

Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study

Background/Purpose: Pharmacogenetics is a potential driver of the “East Asian paradox,” in which East Asian acute coronary syndrome (ACS) patients receiving dual antiplatelet therapy (DAPT) with clopidogrel following percutaneous coronary intervention (PCI) demonstrate higher levels of platelet reac...

Full description

Bibliographic Details
Main Authors: Feng-Yu Kuo, Cheng-Han Lee, Wei-Ren Lan, Cheng-Huang Su, Wen-Lieng Lee, Yi-Chih Wang, Wei-Shiang Lin, Pao-Hsien Chu, Tse-Min Lu, Ping-Han Lo, Shuji Tsukiyama, Wei-Chen Yang, Li-Chung Cheng, Chien-Lung Huang, Wei-Hsian Yin, Ping-Yen Liu
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Journal of the Formosan Medical Association
Subjects:
Acute coronary syndrome
Clopidogrel
CYP2C19
Percutaneous coronary intervention
Prasugrel
Online Access:http://www.sciencedirect.com/science/article/pii/S092966462200033X

Internet

http://www.sciencedirect.com/science/article/pii/S092966462200033X

Similar Items